These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 23975599

  • 1. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W, Wang M, Wang L, Ji S, Zhang J, Zhang C.
    Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
    [Abstract] [Full Text] [Related]

  • 2. Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity.
    Wang Z, Zhang H, Dai L, Song T, Li P, Liu Y, Wang L.
    Cell Biochem Biophys; 2015 Sep; 73(1):213-9. PubMed ID: 25721870
    [Abstract] [Full Text] [Related]

  • 3. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Ma Y, Wang J, Liu L, Zhu H, Chen X, Pan S, Sun X, Jiang H.
    Cancer Lett; 2011 Feb 01; 301(1):75-84. PubMed ID: 21078540
    [Abstract] [Full Text] [Related]

  • 4. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    Chen G, Wang K, Yang BY, Tang B, Chen JX, Hua ZC.
    Int J Oncol; 2012 Jan 01; 40(1):139-47. PubMed ID: 21947421
    [Abstract] [Full Text] [Related]

  • 5. Icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer.
    Shi DB, Li XX, Zheng HT, Li DW, Cai GX, Peng JJ, Gu WL, Guan ZQ, Xu Y, Cai SJ.
    Cell Biochem Biophys; 2014 Jul 01; 69(3):523-30. PubMed ID: 24435883
    [Abstract] [Full Text] [Related]

  • 6. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Jiang H, Ma Y, Chen X, Pan S, Sun B, Krissansen GW, Sun X.
    Cancer Sci; 2010 Apr 01; 101(4):975-83. PubMed ID: 20219070
    [Abstract] [Full Text] [Related]

  • 7. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
    Song J, Zhao Z, Fan X, Chen M, Cheng X, Zhang D, Wu F, Ying X, Ji J.
    Oncotarget; 2016 Oct 25; 7(43):70504-70515. PubMed ID: 27655700
    [Abstract] [Full Text] [Related]

  • 8. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY, Lam SK, Li YY, Fong BM, Mak JC, Ho JC.
    Lung Cancer; 2013 Nov 25; 82(2):222-30. PubMed ID: 24041618
    [Abstract] [Full Text] [Related]

  • 9. Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells.
    Shen P, Jiang T, Lu H, Han H, Luo R.
    Cell Biol Int; 2011 Aug 25; 35(8):803-10. PubMed ID: 21418039
    [Abstract] [Full Text] [Related]

  • 10. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W, Adachi M, Zhang R, Zhou J, Zhu D.
    Pancreas; 2009 May 25; 38(4):e114-23. PubMed ID: 19342982
    [Abstract] [Full Text] [Related]

  • 11. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y.
    Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444
    [Abstract] [Full Text] [Related]

  • 12. Normoxically overexpressed hypoxia inducible factor 1-alpha is involved in arsenic trioxide resistance acquisition in hepatocellular carcinoma.
    Tung JN, Cheng YW, Hsu CH, Liu TZ, Hsieh PY, Ting LL, Ko HL, Chang YJ, Chiou JF, Wu AT.
    Ann Surg Oncol; 2011 May 08; 18(5):1492-500. PubMed ID: 21181559
    [Abstract] [Full Text] [Related]

  • 13. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    Luo Q, Li Y, Lai Y, Zhang Z.
    J Toxicol Sci; 2015 Jun 08; 40(3):349-63. PubMed ID: 25972196
    [Abstract] [Full Text] [Related]

  • 14. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C, Zhou R, Zhou Q, Chang Y, Jiang M.
    Life Sci; 2016 Dec 01; 166():34-40. PubMed ID: 27717846
    [Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Zhao XS, Song PL, Sun B, Jiang HC, Liu TF.
    Hepatobiliary Pancreat Dis Int; 2009 Oct 01; 8(5):510-7. PubMed ID: 19822495
    [Abstract] [Full Text] [Related]

  • 16. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    Shen L, Zhang G, Lou Z, Xu G, Zhang G.
    BMC Complement Altern Med; 2017 Feb 10; 17(1):106. PubMed ID: 28187727
    [Abstract] [Full Text] [Related]

  • 17. All-trans retinoic acid and arsenic trioxide induce apoptosis and modulate intracellular concentrations of calcium in hepatocellular carcinoma cells.
    Wei J, Ye C, Liu F, Wang W.
    J Chemother; 2014 Dec 10; 26(6):348-52. PubMed ID: 25068185
    [Abstract] [Full Text] [Related]

  • 18. SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
    Huang A, Yue D, Liao D, Cheng L, Ma J, Wei Y, Tong A, Cheng P.
    Oncol Rep; 2016 Dec 10; 36(6):3283-3290. PubMed ID: 27748945
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH, Kim JH, Yu YS, Kim DH, Kim CJ, Kim KW.
    Invest Ophthalmol Vis Sci; 2009 Apr 10; 50(4):1819-23. PubMed ID: 19060284
    [Abstract] [Full Text] [Related]

  • 20. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
    Lam SK, Leung LL, Li YY, Zheng CY, Ho JC.
    Lung Cancer; 2016 Nov 10; 101():111-119. PubMed ID: 27794399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.